The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
James Condulis is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/28/2025 | SLNO | Buy Now | Soleno Therapeutics | $75.58 | 42.89% | James Condulis53% | $74 → $108 | Maintains | Buy | Get Alert |
03/05/2025 | SLNO | Buy Now | Soleno Therapeutics | $75.58 | -2.09% | James Condulis53% | → $74 | Reinstates | → Buy | Get Alert |
01/22/2025 | CYTK | Buy Now | Cytokinetics | $30.75 | 160.16% | James Condulis53% | → $80 | Initiates | → Buy | Get Alert |
01/22/2025 | EWTX | Buy Now | Edgewise Therapeutics | $14.79 | 102.84% | James Condulis53% | → $30 | Initiates | → Hold | Get Alert |